Skip to main content
. 2020 Feb 6;10:80. doi: 10.3389/fonc.2020.00080

Figure 2.

Figure 2

(A) Kaplan–Meier estimates of BCFI and ever MHT use. The number of patients is indicated at each follow-up. The study is ongoing, and the number of patients decreases with each follow-up. (B) Kaplan Meier estimates of OS and ever MHT use. The number of patients is indicated at each follow-up. The study is ongoing; thus, the number of patients decreases with each follow-up.